Renosave oral solution is a medication that contains two active ingredients N-Acetyl-L-Cysteine + Taurine. It is used in the treatment of diabetic kidney disease, a condition that can occur as a result of diabetes or a sudden increase in blood sugar levels. If left untreated, diabetic kidney disease can progress to kidney failure. N-Acetylcysteine acts as a protective agent against certain pharmaceutical drugs, such as paracetamol (acetaminophen), and helps to prevent liver damage caused by overdose or toxicity. This drug is contraindicated in individuals with known hypersensitivity or allergy to it or its component. The use of Renosave oral solution should be avoided with topical antibiotics for the relief of dry eye syndrome. Combining this medicine with topical antibiotics can increase the risk of severe adverse reactions. It is important to consult your physician to determine the appropriate treatment options for keratoconjunctivitis and dry eye syndrome. It is important to note that this medicine is not recommended for use in patients experiencing a severe and sudden asthma attack. During treatment with this medicine, asthma patients should be closely monitored. Notify your physician if you develop any symptoms related to it. Inform your doctor of any heart, thyroid, kidney, or liver disease. Your physician may prescribe you a low dose and perform regular blood tests. It is generally recommended to avoid using Renosave oral solution during pregnancy and breastfeeding unless it is necessary.